Investors & Media

SEC Filing Details

Document Details

Form
SC TO-T
Filing Date
Jun 7, 2022
Document Date
Jun 7, 2022
Form Description
Tender offer schedule and amendment filed by a third party.
Filing Group
Mergers & Acquisitions
Company
Entasis Therapeutics Holdings Inc.
Issuer
ENTASIS THERAPEUTICS HOLDINGS INC.

"Antibiotic resistance is a worldwide problem that is constantly growing. New forms of resistance can spread quickly and across continents. At Entasis, we discover and develop novel antibacterials to address the serious medical need posed by multi-drug resistant bacterial infections."

— Ruben Tommasi, Chief Scientific Officer